发明名称 |
COMBINATION THERAPY FOR TREATMENT OF DIABETES AND CONDITIONS RELATED THERETO AND FOR TREATMENT OF CONDITIONS AMELIORATED BY INCREASING BLOOD GLP-1 LEVEL |
摘要 |
<P>PROBLEM TO BE SOLVED: To provide a new approach to lowering a blood glucose level in a subject and to increasing a blood GLP-1 level in a subject. <P>SOLUTION: The invention relates to combination of an amount of a GPR119 agonist with an amount of a dipeptidyl peptidase IV (DPP-IV) inhibitor such that the combination provides an effect in lowering a blood glucose level in a subject or in increasing a blood GLP-1 level in a subject over that provided by the amount of the GPR119 agonist or the amount of the DPP-IV inhibitor alone and the use of such a combination for treating or preventing diabetes and conditions related thereto or conditions ameliorated by increasing a blood GLP-1 level. The invention also relates to the use of a G protein-coupled receptor to screen for GLP-1 secretagogues. <P>COPYRIGHT: (C)2011,JPO&INPIT |
申请公布号 |
JP2011184458(A) |
申请公布日期 |
2011.09.22 |
申请号 |
JP20110127707 |
申请日期 |
2011.06.07 |
申请人 |
ARENA PHARMACEUTICALS INC |
发明人 |
CHU ZHI-LIANG;LEONARD JAMES N;AL-SHAMMA HUSSIEN A;JONES ROBERT M |
分类号 |
A61K45/06;A61P9/10;A61P17/02;A61P25/02;A61P25/14;A61P25/16;A61P25/28;A61P43/00;C12N15/09 |
主分类号 |
A61K45/06 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|